Cefdinir Use in Penicillin Allergy
Cefdinir is a third-generation cephalosporin and has low cross-reactivity with true IgE-mediated penicillin allergy. [1][3] For most patients with a penicillin allergy history, cefdinir can be administered without additional precautions when the penicillin allergy is unverified and nonanaphylactic. [1]
Risk Stratification by Penicillin Allergy History
- Unverified, nonanaphylactic penicillin allergy: a cephalosporin can be administered without testing or additional precautions. [1]
- Immediate penicillin allergy history: a non–cross-reactive cephalosporin can be administered by full dose or drug challenge. [1]
- Penicillin allergy with severe delayed cutaneous or organ involvement (e.g., Stevens-Johnson syndrome or toxic epidermal necrolysis): penicillin and other beta-lactams should be avoided indefinitely and referral for specialist evaluation is recommended. [3]
Cephalosporin Cross-Reactivity Expectations
- Third-generation cephalosporins (including cefdinir-class agents) have lower cross-reactivity with IgE-mediated penicillin allergy than first- and second-generation cephalosporins. [3]
- Reported cross-reactivity between penicillin allergy and third-generation cephalosporins is <1% in CDC-referenced data. [3]
- Anaphylaxis from cephalosporins in persons with a penicillin allergy label is extremely rare and is estimated at one per 52,000 persons (CDC-referenced estimate). [3]
Medication Selection Algorithm
- If the penicillin allergy history is unverified and nonanaphylactic, cefdinir administration is appropriate without routine penicillin skin testing. [1]
- If the penicillin allergy history is immediate (IgE-type), cefdinir can be given as a full dose or via supervised drug challenge when the cephalosporin is considered non–cross-reactive. [1]
- If the penicillin reaction was severe delayed cutaneous or involved organs, cefdinir should be avoided and specialist evaluation should be pursued. [3]
Initiation Thresholds and Practical Administration
- No special dose initiation strategy is recommended for unverified nonanaphylactic penicillin allergy histories. [1]
- For immediate penicillin allergy histories, administration by full dose or drug challenge is supported for non–cross-reactive cephalosporins. [1]
Common Pitfalls to Avoid
- Treating any reported “penicillin allergy” as true IgE-mediated allergy can lead to unnecessary avoidance of beta-lactams. [3]
- Using cephalosporins in patients with a history of severe delayed cutaneous reactions or severe non-IgE-mediated reactions without specialist evaluation is discouraged. [3]
Target Outcome of Therapy
The goal is safe beta-lactam therapy with avoidance of severe hypersensitivity syndromes while using cephalosporins when cross-reactivity risk is low based on allergy history. [1][3]
Key Safety Bottom-Point
Cefdinir is generally considered safe in patients with penicillin allergy labels when the allergy is unverified or nonanaphylactic. [1] Cefdinir should be avoided in patients with a history of severe delayed cutaneous or severe non-IgE-mediated reactions to penicillin and other beta-lactams should be managed via allergy specialist evaluation. [3]